Press release from Companies: First subjects screened in Aptahem’s FIH study with Apta-1

Press release from Companies: Första screening av friska frivilliga i Aptahems klinisk fas 1-studie

Press release from Companies: Aptahem reports added positive and significant biological effect in an extended Corona virus-induced acute lung injury model treated with Apta-1

Press release from Companies: Aptahem meddelar ytterligare positiva och signifikanta biologiska effekter i en utökad coronavirus-orsakad lungskademodell med behandling av Apta-1

Press release from Companies: Aptahem’s CEO interviewed during the Biotechgate conference

Press release from Companies: Aptahems VD intervjuad under Biotechgate-konferensen

Press release from Companies: Sista dag för teckning i Aptahem AB:s (publ) företrädesemission

Press release from Companies: Newsletter November 2022

Press release from Companies: Nyhetsbrev november 2022

Press release from Companies: Nomination committee for Aptahem Annual General Meeting 2023

Press release from Companies: Aptahems valberedning inför årsstämman 2023

Press release from Companies: BioStock Studio: Aptahems vd om kommande milstolpar